COMP 006
Brief description of study
In this study, the aim is to assess the efficacy after one and two administrations of COMP360 25 mg or COMP360 10 mg versus COMP360 1 mg for reducing symptom severity in TRD, when administered with psychological support.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting